ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
61 hedge funds and large institutions have $33.5M invested in Adamas Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 25 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 22
Holders
61
Holding in Top 10
1
Calls
$66K
Puts
$29K
Top Buyers
| 1 | +$2.46M | |
| 2 | +$1.92M | |
| 3 | +$1.19M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$521K |
| 5 |
Jane Street
New York
|
+$351K |
Top Sellers
| 1 | -$5.2M | |
| 2 | -$3.03M | |
| 3 | -$1.04M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.01M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$594K |